Upland Software
Upland Software's revenue fell 21.1% to $217 million in fiscal 2025. Its operating margin was 2.0%, up from −37.2% a year earlier. Free cash flow was $24 million, up 4.7%. The diluted share count rose 3.0%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Income statement
Upland Software lost money in fiscal 2025: a net loss of $39 million.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 189 | 249 | 237 | 56 | 29 |
| Debt incl. finance leases | 518 | 515 | 477 | 290 | 232 |
| Net debt (negative means net cash) | 329 | 266 | 240 | 234 | 203 |
| Net debt to EBITDA | 18.0x | 16.7x | — | — | 5.5x |
| Debt to equity | 1.6x | 1.7x | 3.8x | — | — |
| Interest coverage | −1.2x | −1.4x | −8.8x | −11.4x | 0.2x |
| Current ratio | 1.7x | 2.1x | 2.3x | 1.0x | 0.8x |
| Quick ratio | 1.7x | 2.1x | 2.3x | 1.0x | 0.8x |
Cash flow
Projections
Project Upland Software's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 20, 2025 and November 19, 2026, no insider bought Upland Software shares on the open market, and 1 insider sold $25,687, all of it under trading plans set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Timothy MattoxDirector | Sold plan | 847 | $4.28 | $3,627 | Form 4 |
| Aug 6, 2026 | Timothy MattoxDirector | Sold plan | 1,000 | $4.27 | $4,270 | Form 4 |
| Aug 5, 2026 | Timothy MattoxDirector | Sold plan | 1,000 | $4.53 | $4,530 | Form 4 |
| Aug 4, 2026 | Timothy MattoxDirector | Sold plan | 1,000 | $4.33 | $4,330 | Form 4 |
| Aug 3, 2026 | Timothy MattoxDirector | Sold plan | 1,000 | $4.45 | $4,450 | Form 4 |
| Jul 31, 2026 | Timothy MattoxDirector | Sold plan | 1,000 | $4.48 | $4,480 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | 5 of 9 | 7 of 9 | 5 of 9 |
| Rule of 40 | 10.2% | 0.8% | −9.8% |
| Altman Z'' | −1.61 | −5.07 | −5.43 |
| Accruals ratio | −23.2% | −19.6% | −13.7% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Fail | Fail | Fail |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Pass | Pass |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Pass | Fail |
| Current ratio rose | Pass | Fail | Fail |
| Share count didn't rise | Fail | Pass | Fail |
| Gross margin rose | Pass | Pass | Pass |
| Revenue rose relative to assets | Fail | Pass | Pass |
| F-score | 5 of 9 | 7 of 9 | 5 of 9 |
Compare
Put Upland Software side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Upland Software | FY25 | −21.1% | 2.0% | 11.3% | 1.9% | 5.5x | 5 | |
| Exzeo Group | FY25 | 62.0% | 48.9% | 44.9% | — | — | — | Compare |
| i3 Verticals | FY25 | 11.5% | 1.8% | 1.8% | 0.4% | −2.1x | 5 | Compare |
| VTEX | FY25 | 6.1% | 7.5% | 13.4% | 39.9% | −9.0x | 6 | Compare |
| Definitive Healthcare | FY25 | −4.2% | −92.9% | 15.3% | −38.3% | — | 5 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 75 | 98 | 150 | 223 | 292 | 302 | 317 | 298 | 275 | 217 |
| Revenue growth | 7.0% | 31.0% | 53.0% | 48.5% | 31.1% | 3.5% | 5.1% | −6.1% | −7.7% | −21.1% |
| Gross profit | 47 | 64 | 101 | 154 | 193 | 203 | 214 | 202 | 194 | 162 |
| Research and development | 15 | 16 | 21 | 29 | 39 | 43 | 46 | 49 | 47 | 36 |
| Operating income | −8 | −11 | −6 | −24 | −24 | −35 | −40 | −164 | −102 | 4 |
| Net income | −14 | −19 | −11 | −45 | −51 | −58 | −68 | −180 | −113 | −39 |
| Diluted EPS (US$) | −0.82 | −1.02 | −0.54 | −1.96 | −1.92 | −1.92 | −2.23 | −5.77 | −4.26 | −1.56 |
| Diluted shares (millions) | 16 | 18 | 20 | 23 | 27 | 30 | 32 | 32 | 28 | 29 |
| Cash flow | ||||||||||
| Cash from operations | 4 | 8 | 7 | 12 | 36 | 42 | 30 | 50 | 24 | 26 |
| Capital expenditure | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Free cash flow | 3 | 7 | 6 | 11 | 35 | 41 | 29 | 49 | 23 | 24 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 12 | 110 | 161 | 216 | 68 | 92 | 62 | 0 | 0 | 0 |
| Stock-based compensation | 4 | 10 | 14 | 26 | 42 | 54 | 42 | 23 | 15 | 9 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 29 | 22 | 17 | 175 | 250 | 189 | 249 | 237 | 56 | 29 |
| Debt incl. finance leases | 48 | 111 | 280 | 525 | 522 | 518 | 515 | 477 | 290 | 232 |
| Total assets | 151 | 281 | 483 | 897 | 1,011 | 1,029 | 1,114 | 870 | 530 | 413 |
| Total liabilities | 92 | 190 | 396 | 684 | 705 | 713 | 692 | 626 | 425 | 332 |
| Shareholders' equity | 59 | 91 | 87 | 213 | 307 | 316 | 309 | 126 | −18 | −48 |
| Margins and ratios | ||||||||||
| Gross margin | 63.1% | 65.7% | 67.6% | 69.0% | 66.3% | 67.1% | 67.3% | 67.7% | 70.5% | 74.8% |
| Operating margin | −11.4% | −11.4% | −3.7% | −10.9% | −8.2% | −11.5% | −12.7% | −55.0% | −37.2% | 2.0% |
| Net margin | −18.1% | −19.1% | −7.2% | −20.4% | −17.6% | −19.3% | −21.6% | −60.4% | −41.0% | −17.9% |
| Free cash flow margin | 4.3% | 7.5% | 4.3% | 5.0% | 11.8% | 13.4% | 9.2% | 16.4% | 8.5% | 11.3% |
| Rule of 40 (growth + FCF margin) | 11.2% | 38.5% | 57.3% | 53.5% | 42.9% | 17.0% | 14.2% | 10.2% | 0.8% | −9.8% |
| Return on capital | −9.4% | −6.8% | −1.7% | −4.2% | −3.3% | −4.5% | −5.2% | −27.5% | −27.8% | 1.9% |
| Return on equity | −22.7% | −24.9% | −12.1% | −30.2% | −19.7% | −18.7% | −21.9% | −82.7% | −208.8% | — |
| Return on assets | −9.9% | −8.7% | −2.8% | −6.6% | −5.4% | −5.7% | −6.4% | −18.1% | −16.1% | −8.2% |
| Net debt to EBITDA | 15.1x | 114.2x | 16.7x | 34.0x | 11.6x | 18.0x | 16.7x | — | — | 5.5x |